MAP2K1 and carcinoma of esophagus: Conversely, another study found that STAT3 and MEK1/2 signalling inhibitors have a similar ability to suppress tumorigenesis, and the combination of both inhibitors more potently affected these phenotypes in oesophageal cancer [22].